Sialyl glycopeptide—a key probe that reveals the secrets of glycosylation 189035-43-6

Sialylglycopeptide (SIALYLGLYCOPEPTIDE) is an important glycopeptide compound with a clear structure and containing terminal sialic acid. As a core tool molecule in the field of glycobiology and glycoprotein research, it plays an irreplaceable role in understanding the molecular dialogue of life processes and developing targeted therapies and diagnostic strategies.

Chemical Information

Chemical name: SIALYLGLYCOPEPTIDE

Common name: Sialyl glycopeptide

Chemical formula: C112H189N15O70

Molecular weight: 2865.76 g/mol

CAS number: 189035-43-6

Category: SGP Products

Structural features

The subtlety of sialoglycopeptides lies in their structure that combines peptide chains and complex sugar chains, especially the presence of terminal sialic acid residues:

Key terminal modifications: Sialic acid (such as N-acetylneuraminic acid) usually serves as the terminal sugar group of the sugar chain, and its negatively charged carboxyl group is crucial in intermolecular interactions. This modification greatly affects the physicochemical properties and biological activities of the entire glycoconjugate.

l Intermediary between structure and function: This molecule has both the programmability/specificity of peptides and the multivalency and high hydrophilicity of sugar chains. Its structure simulates the local microenvironment of glycosylation sites on natural glycoproteins, providing a highly relevant model for research.

Cornerstone of specific recognition: Many important biological recognition processes, such as intercellular communication, pathogen attachment, and immune modulation, rely on highly specific recognition of specific sialylated sugar structures by proteins (e.g., lectins, antibodies). Sialyl glycopeptides are precise probes for such interaction studies.

Main applications and advantages

Core tools for glycobiology and drug discovery

Receptor-ligand interaction research: As a standard or immobilized ligand, it is used to study the specific binding of influenza virus hemagglutinin, bacterial toxins, and various lectins (such as the Siglecs family) in the human body to sialylated sugar chains to elucidate the infection and immune mechanisms.

Drug and vaccine research and development platform: In the development of antiviral drugs and new vaccines (especially for influenza and bacterial infections), sialoglycopeptides can be used as templates for the design of key antigens or inhibitors, and are used to screen and evaluate candidate molecules that can block pathogen adhesion.

Analysis of glycoprotein biosimilars: In the quality control of biological products such as therapeutic monoclonal antibodies, sialoglycopeptides can be used as reference materials to analyze and monitor the consistency of product glycosylation modifications (especially sialylation levels), which is closely related to the efficacy, stability and immunogenicity of the drug.

Diagnostic development and biomarker research

Disease-related glycomarkers: Various diseases, such as cancer, autoimmune diseases, and inflammatory diseases, are often accompanied by abnormal changes in the sialylation pattern of cell surface glycoproteins. Specific sialoglycopeptide structures can serve as potential biomarkers for the development of highly specific diagnostic assays.

l Detection reagent development: As a coating antigen or competitive inhibitor, it can be used to develop ELISA or other affinity-based detection kits for detecting specific lectin or anti-sialoglyco antibody levels, serving scientific research and clinical diagnosis.

Enzymology and Metabolism Research

Glycosyltransferase/glycosidase substrates or inhibitors: As natural substrate analogs of sialyltransferase or sialidase, they are used to study the kinetics, specificity and regulatory mechanisms of these key enzymes, and can also be used as a starting point for designing enzyme inhibitors.

Conclusion

Sialyl glycopeptide is much more than a complex biochemical molecule, it is a sophisticated bridge connecting glycochemistry and life functions. From decoding the codes of cell communication to pioneering new pathways for treating infectious diseases and cancer, to ensuring the quality of biopharmaceuticals, its value runs through a wide range of fields from basic science to translational medicine. As an important member of SGP Products, sialoglycopeptides with well-defined structures continue to provide key materials and inspiration for scientific researchers and drug developers to reveal the mysteries of life and create the next generation of therapies.

The above information is provided by the editor of KASONS and is for scientific research only.